High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their...
from NDTV News - World-news https://ift.tt/3lCYC5E
from NDTV News - World-news https://ift.tt/3lCYC5E
Comments
Post a Comment